Molecular Mechanisms of Action and Potential Biomarkers of Growth Inhibition of Dasatinib (BMS-354825) on Hepatocellular Carcinoma Cells
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-267
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2013
Authors
Publisher
Springer Science and Business Media LLC